Health
COVID: new antibody treatment could offer up to 18 months’ protection against severe disease – The Conversation UK
AstraZeneca’s durable monoclonal antibody treatment has shown promise in phase 3 clinical trials.
A new treatment could soon help protect people from developing severe COVID. AstraZeneca has just released results from a phase 3 clinical trial the final stage of testing before a drug is authorised that suggest its new COVID treatment, AZD7442, is effective…
Continue Reading
-
General15 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News17 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
Noosa News20 hours agoAustralia’s biggest sheep drive, and the young drover history forgot
-
Noosa News16 hours agoPolice appeal for information after two men found dead